Table 5.

EVs as potential biomarkers in lung cancer.

Biomarker Types	Specific Markers	Tumour	Expression	Ref.
miRNAs	miR-182	LC	Upregulated	[113]
	miR-21-5p	LAC	Upregulated	[104]
	miR-520c-3p	LC	Upregulated	[107]
	miR-19b-3p	LAC	Upregulated	[104]
	miR-221-3p	LAC	Upregulated	[104]
	miR-502-5p	LAC	Upregulated	[105]
	miR-376a-5p	LAC	Upregulated	[105]
	miR-1974	LAC	Upregulated	[105]
	miR-378a	LAC	Upregulated	[105]
	miR-379	LAC	Upregulated	[105]
	miR-151a-5p	LAC	Upregulated	[105]
	miR-139-5p	LAC	Upregulated	[105]
	miR-200b-5p	LAC	Upregulated	[105]
	miR-190b	LAC	Upregulated	[105]
	miR-30a-3p	LAC	Upregulated	[105]
	miR-629	LAC	Upregulated	[105]
	miR-17	LAC	Upregulated	[105]
	miR-100	LAC	Upregulated	[105]
	miR-154-3p	LAC	Upregulated	[105]
	miR-505-5p	LAC	Upregualated	[106]
	miR-382-3p	LAC	Downregulated	[106]
	miR-1274b	LC	Upregulated	[107]
	miR-1-3p	LC	Downregulated	[111]
	miR-144-5p	LC	Downregulated	[111]
	miR-150-5p	LC	Upregulated	[112]
	miR-210	LC	Upregulated	[113]
Proteins	EGFRvIII	LC	Downregulated	[36]
	CD9	LC	Overexpressed	[36]
	TAG72	LC	Overexpressed	[36]
	MUC	LC	Overexpressed	[36]
	CD142	LC	Overexpressed	[36]
	N-cadherin	LC	Overexpressed	[36]
	CD163	LC	Overexpressed	[36]
	CD63	LC	Overexpressed	[36]
	CD81	LC	Downregulated	[36]
	TSG101	LC	Downregulated	[36]
	Hsp90	LC	Downregulated	[36]
	EpCam	LC	Downregulated	[36]

LC: Lung Cancer; LAC: Lung Adenocarcinoma.